| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Summit Corp plc (SMMT) | JMP Securities/ Oppenheimer | $40.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| DTLR Holding (DTLR) | Baird/ Piper Jaffray/ Stifel | 5.77 | $12.00 | $14.00 | $75.00 | n.a. |
| Kolltan Pharmaceuticals (KLTN) | Leerink Partners/ Stifel | $86.25 | n.a. | |||
| New Terms | ||||||
| Asante Solutions (PUMP) | Leerink Partners/ Cowen and Company | 3.50 | $13.00 | $15.00 | $49.00 | 1-Star |
| Avenue Financial (AVNU) | Keefe, Bruyette & Woods (A Stifel Company) | 2.50 | $11.00 | $13.00 | $30.00 | n.a. |
| Columbia Pipeline Partners LP (CPPL) | Barclays/ Citigroup/ BofA Merrill Lynch/ Goldman Sachs/ J.P. Morgan/ Morgan Stanley/ Wells Fargo Securities | 40.00 | $19.00 | $21.00 | $800.00 | 2-Stars |
| Easterly Government Properties (DEA) | Citigroup/ Raymond James/ RBC Capital Markets | 12.00 | $14.00 | $16.00 | $180.00 | 1-Star |
| Inovalon Holdings (INOV) | Goldman Sachs/ Morgan Stanley/ Citigroup/ BofA Merrill Lynch/ UBS Investment Bank | 22.22 | $21.00 | $24.00 | $500.00 | n.a. |
| Nexvet Biopharma plc (NVET) | BofA Merrill Lynch/ Cowen and Company | 4.00 | $13.00 | $16.00 | $58.00 | 1-Star |
| Shake Shack (SHAK) | J.P. Morgan/ Morgan Stanley | 5.00 | $17.00 | $19.00 | $90.00 | 4-Stars |
| Sol-Wind Renewable Power, LP (SLWD) | UBS Investment Bank/ Citigroup | 8.70 | $19.00 | $21.00 | $174.00 | n.a. |
| Spark Therapeutics (ONCE) | J.P. Morgan/ Credit Suisse | 6.50 | $19.00 | $21.00 | $130.00 | 3-Stars |
| Zosano Pharma (ZSAN) | Ladenburg Thalmann/ Roth Capital Partners | 4.30 | $10.00 | $12.00 | $47.30 | 1-Star |
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Jan. 26, 2015 | Manager(s) | Offered | Raised | Price | 1/30/15 | Change |
| Spark Therapeutics (ONCE) | J.P. Morgan/ Credit Suisse | 7.00 | $161.00 | $23.00 | $50.00 | 117.39% |
| Shake Shack (SHAK) | J.P. Morgan/ Morgan Stanley | 5.00 | $105.00 | $21.00 | $45.90 | 118.57% |
| InfraREIT (HIFR) | BofA Merrill Lynch/ Citigroup | 20.00 | $460.00 | $23.00 | $26.60 | 15.65% |
| Entellus Medical (ENTL) | BofA Merrill Lynch/ Piper Jaffray | 4.60 | $78.20 | $17.00 | $21.59 | 27.00% |
| Ascendis Pharma A/S (ASND) | BofA Merrill Lynch/ Leerink Partners | 5.00 | $90.00 | $18.00 | $19.83 | 10.17% |
| Flex Pharma (FLKS) | Jefferies/ Piper Jaffray | 5.40 | $86.40 | $16.00 | $14.74 | -7.88% |
| Avinger (AVGR) | Canaccord Genuity/ Cowen | 5.00 | $65.00 | $13.00 | $13.50 | 3.85% |
| Zosano Pharma (ZSAN) | Ladenburg Thalmann/ Roth Capital Partners | 4.50 | $49.50 | $11.00 | $11.09 | 0.82% |
| Tracon Pharmaceuticals (TCON) | Wells Fargo Securities/ Stifel | 3.60 | $36.00 | $10.00 | $9.40 | -6.00% |
| Presbia PLC (LENS) | Jefferies | 4.17 | $41.67 | $10.00 | $6.51 | -34.90% |
